Patent · US Active

TLR-independent small molecule adjuvants

US9918959B2 · kind B2 · utility

1Cited by
3References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 5, 2015
Grant dateMar 20, 2018
Priority date
Expiry dateAug 5, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A TLR-independent adjuvant compound that corresponds in structure to Formula I, below, or its pharmaceutically acceptable salt is disclosed inwhich X, Y, Z, n, R1, R2, R3, R4 and W are defined within. Also disclosed are a method of its preparation and use, as well as a pharmaceutical composition containing the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.